Wyeth's Bob Essner - CEO pay
Bob Essner - Wyeth 
Total Compensation: $24.1M
2007 Revenue: $22.4B
2006 Revenue: $20.35B
Change: 10%
Details: Bob Essner's (pictured) 2007 compensation fell to $24.1 million from more than $32 million in 2006, which included $1.7 million in base pay, $10.1 million in stock awards, $4.7 million in options and a $3.2 million bonus. Essner also spent $15,000 on personal use of a company car and driver and $95,000 on air travel. Wyeth's new CEO Bernard Poussot (photo), saw his package decline to $12.7 million from $14.4 million. Poussot took over for outgoing CEO Essner January 1, 2008.
Wyeth News:
Wyeth names Poussot CEO
Wyeth to slash another 1,200 jobs
1,200 Wyeth reps out of work
Wyeth, Pfizer chiefs see pay decline
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: